To wrap up my interviews with Dr. Susan O’Brian from ASCO 2014, I’d like to share this fourth and final thoughtful audio interview despite all its hisses and pops.
In this segment, Dr. O’Brien and I discuss the place of CT scans in clinical trials and in the real world of CLL therapy. Her answer is not black or white but is balanced and well considered.
Next Dr. O’ Brien gives as a nuanced response to the question of what might be the possible role for chemo-immunotherapy in and out of trials.
Spoiler alert: Consider FCR frontline if you are young, healthy, mutated, and trisomy 12. But only under those circumstances.
Here is Dr. O’Brien
Dr. Brian Koffman 12/12/2014